ProfileGDS5822 / ILMN_2474195
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 6% 2% 13% 4% 10% 5% 8% 6% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 18.56
GSM1276600PDAC Late Ablation Control 27.72
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.713
GSM1276603PDAC Late Ablation 25.74
GSM1276604PDAC Late Ablation 38.210
GSM1303940PDAC Late Ablation_anti-CTLA4 16.95
GSM1303941PDAC Late Ablation_anti-CTLA4 26.18
GSM1303942PDAC Late Ablation_anti-CTLA4 34.56